(Q40414089)

English

Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries

scientific article published on 20 October 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 September 2017

Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries (English)

1 reference

Europe PubMed Central

20 September 2017

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

Stefano Fagiuoli

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

William Rosenberg

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Z Younossi

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

A Brown

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

M Buti

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

S Mauss

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

L Serfaty

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

A Srivastava

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

N Smith

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

M Stepanova

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

R Beckerman

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

20 October 2015

1 reference

Europe PubMed Central

20 September 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

217-226

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Epidemiology of hepatitis C virus (HCV) infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Global epidemiology of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Global distribution and prevalence of hepatitis C virus genotypes

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Global epidemiology and genotype distribution of the hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Epidemiology of hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Manifestations of chronic hepatitis C virus infection beyond the liver

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Hepatitis C and work impairment: a review of current literature

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

The societal burden of chronic liver diseases: results from the COME study.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

The burden of hepatitis C in Europe from the patients' perspective: a survey in 5 countries

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

The burden of viral hepatitis C in Europe: a propensity analysis of patient outcomes

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Comparison of quality of life, work productivity and medical resource utilization of peginterferon alpha 2a vs the combination of interferon alpha 2b plus ribavirin as initial treatment in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: the VALENCE study

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Work productivity among treatment-naïve patients with genotype 1 chronic hepatitis C infection receiving telaprevir combination treatment

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Costs of illness in cost-effectiveness analysis. A review of the methodology

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Socioeconomic status in HCV infected patients - risk and prognosis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

The changing burden of hepatitis C virus infection in the United States: model-based predictions.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

The burden of untreated hepatitis C virus infection: a US patients' perspective

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12483

21 January 2018

Identifiers

10.1111/JVH.12483

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26482680%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40414089&oldid=1897149516"